Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited Consolidated & Standalone ....
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited has informed the BSE that its Board of Directors will meet on Friday, 13 February 2026, to consider and approve the Unaudited Consolidated and Standalone Financial Results for the quarter ended 31 December 2025 (Q3 FY26). The company has also confirmed that the trading window for dealing in its equity shares has been closed for all designated persons and their immediate relatives from 1 January 2026 and will remain so until 48 hours after the results are declared. Any other business items may be taken up with the Chairman's permission. The intimation has been signed by Pranjal Deshmukh, Company Secretary & Compliance Officer.
This is a routine procedural filing ahead of Q3 FY26 results and carries no immediate impact on shareholders; investors should watch for the actual results on or after 13 February 2026 for performance insights. The closed trading window signals that insiders are barred from trading until results are out, which is standard practice.